Global Medical Exoskeleton Market

Global Medical Exoskeleton Market Size, Share, Growth Analysis, By Technology(Powered and Non-powered), By End-Use(Healthcare, Military) - Industry Forecast 2024-2031


Report ID: SQMIG35A2311 | Region: Global | Published Date: February, 2024
Pages: 157 | Tables: 61 | Figures: 75

Global Medical Exoskeleton Market Insights

Medical Exoskeleton Market size was valued at USD 286.14 million in 2021 and is poised to grow from USD 334.5 million in 2022 to USD 997.46 million by 2030, growing at a CAGR of 16.9% during the forecast period (2023-2030).

The global medical exoskeleton market is a rapidly developing sector within the healthcare industry that offers innovative solutions for individuals with mobility impairments. These wearable robotic devices, known as medical exoskeletons, are designed to enhance the strength and mobility of users, assisting them in performing daily activities with greater ease. In recent years, the medical exoskeleton market has witnessed significant growth due to several factors. The prevalence of disabilities and mobility impairments resulting from factors such as aging populations, chronic diseases, and traumatic injuries has led to a higher demand for assistive technologies that can improve the quality of life for affected individuals. Advancements in robotics, sensor technologies, and artificial intelligence have played a crucial role in the development of more advanced medical exoskeletons. These devices have become lighter, more compact, and more comfortable to wear, making them more practical and widely accepted by users. Despite the promising growth prospects, the medical exoskeleton market faces challenges that need to be addressed. High costs, limited reimbursement policies, and regulatory barriers hinder the widespread adoption of these devices. However, ongoing research and development efforts, along with collaborations between manufacturers, healthcare providers, and regulatory bodies, aim to overcome these obstacles and foster market growth. To summarize, the global medical exoskeleton market is witnessing rapid growth driven by the increasing demand for assistive technologies and advancements in robotics and sensor technologies. These innovative devices have the potential to transform the lives of individuals with mobility impairments, granting them greater independence and improving their overall quality of life. Continued progress, affordability improvements, and expanded applications across sectors are expected as the market continues to evolve.

US Medical Exoskeleton Market is poised to grow at a sustainable CAGR for the next forecast year.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Medical Exoskeleton Market size was valued at USD 286.14 million in 2021 and is poised to grow from USD 334.5 million in 2022 to USD 997.46 million by 2030, growing at a CAGR of 16.9% during the forecast period (2023-2030).

The global medical exoskeleton market has a competitive landscape with several key players operating in the industry. These companies are actively involved in the development, manufacturing, and commercialization of medical exoskeletons. The competitive landscape is dynamic, with companies constantly striving to gain a competitive edge by differentiating their products, improving user experience, and addressing the specific needs of patients and healthcare providers. Partnerships, acquisitions, and collaborations are common strategies employed by companies in this market to expand their geographical presence and strengthen their product portfolios. 'Ekso Bionics (U.S.)', 'ReWalk Robotics (Israel)', 'PARKER HANNIFIN CORP (U.S.)', 'CYBERDYNE INC. (Japan)', 'BIONIK (Canada)', 'Rex Bionics Ltd., (U.K.)', 'B-Temia (Canada)', 'Bioventus (U.S.)', 'Hocoma (Switzerland)', 'Wearable Robotics srl (Italy)', 'ExoAtlet (Luxembourg)', 'Meditouch (Israel)', 'Suit X (U.S.)', 'MarsiBionics (Spain)', 'Rehab-Robotics Company Limited (Hong Kong)', 'Myomo Inc. (U.S.)', 'Focal Meditech (Netherlands)', 'Honda Motor Co., Ltd. (Japan)', 'Wandercraft (France)', 'MEDEXO ROBOTICS (Hong Kong)'

The increase in orthopaedic procedures will slow the market's rate of expansion for medical exoskeletons. Joint replacement procedures for the knee and hip are mostly to blame for the increase in orthopaedic surgery. With an increase in the incidence of vehicle accidents and other disorders, limb amputations have become more common. There has been a significant increase in the number of amputation procedures performed on diabetic individuals with gangrene. These particular elements are what propel market expansion.

Several key market trends are shaping the global medical exoskeleton market. Firstly, there is a growing emphasis on research and development efforts to enhance the capabilities and usability of medical exoskeletons. Manufacturers are focusing on improving the devices' ergonomics, reducing their weight and size, and increasing their functionality to meet the specific needs of users. This trend is driving the development of more advanced and user-friendly medical exoskeletons. In addition, there is a growing trend towards strategic collaborations and partnerships among key stakeholders in the medical exoskeleton market. Manufacturers are collaborating with healthcare providers, research institutions, and regulatory bodies to accelerate product development, ensure safety and compliance, and expand market reach. These collaborations are fostering innovation, knowledge sharing, and market growth. The key market trends in the global medical exoskeleton market include a focus on research and development, expansion into industrial applications, integration of AI and ML technologies, adoption of value-based healthcare models, and strategic collaborations among stakeholders. These trends are shaping the market by driving innovation, expanding applications, improving user experience, increasing reimbursement coverage, and fostering partnerships for mutual growth.

North America dominated the global Medical Exoskeleton market. North America holds a significant market share due to several factors. The region has a well-established healthcare infrastructure, including advanced rehabilitation centers and hospitals, which are early adopters of medical exoskeletons. Additionally, North America has a robust research and development ecosystem, with numerous academic institutions and technology companies actively involved in developing innovative exoskeleton technologies. The presence of major market players and favorable reimbursement policies further contribute to North America's dominance in the market.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Medical Exoskeleton Market

Product ID: SQMIG35A2311

$5,300
BUY NOW GET FREE SAMPLE